4.7 Review

Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Allergy

Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review

Ming Zhao et al.

Summary: Scleroderma consists of two major clinical subsets: systemic sclerosis and localized scleroderma, each with distinct characteristics and clinical manifestations. Systemic sclerosis can lead to organ complications, while localized scleroderma is primarily confined to the skin and subcutaneous tissues.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2022)

Review Medicine, Research & Experimental

Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives

Chiara Sassoli et al.

Summary: Relaxin, a potential medication for fibrotic diseases, has shown promising results in in vitro and in vivo studies by inhibiting fibrogenic pathways and activating fibrosis-generating cells. However, clinical trials have yielded inconclusive results. This review summarizes the molecular mechanisms of fibrosis and critically evaluates the clinical trials, identifying future opportunities for the therapeutic use of relaxin.

CURRENT MOLECULAR MEDICINE (2022)

Review Biochemistry & Molecular Biology

New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction

Xiangyu Zhao et al.

Summary: Fibrosis is a pathological feature of various chronic inflammatory diseases, which can have severe consequences and even be fatal. The imbalance between the production and degradation of extracellular matrix (ECM) leads to excessive accumulation of ECM, with impaired degradation also playing a significant role in fibrosis. Understanding the relationship among macrophages, the MMP/TIMP system, and ECM is crucial for the development of potential therapeutic strategies for fibrosis.

CELL AND BIOSCIENCE (2022)

Article Cell Biology

Minimally invasive, sustained-release relaxin-2 microparticles reverse arthrofibrosis

Jack R. Kirsch et al.

Summary: Significant progress in biotherapeutics for musculoskeletal diseases is still lacking, especially in addressing the complexity of these diseases. Current treatment options fail to target the underlying cause of arthrofibrosis, a debilitating musculoskeletal disease characterized by the accumulation of fibrotic tissue in the joints. Human relaxin-2 (RLX), a hormone with antifibrotic activity, shows promise as a potential therapy for musculoskeletal fibrosis. However, previous clinical programs for RLX have faced challenges due to pharmacokinetic barriers. In this study, researchers designed a drug delivery system that can sustainably release RLX in vitro and in vivo, leading to improved joint range of motion and architecture in a rat model of arthrofibrosis. The expression of RLX receptor, RXFP1, in human tissues relevant to arthrofibrosis further suggests the potential translational application of RLX in a sustained and targeted manner.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

A rat model of arthrofibrosis developed after anterior cruciate ligament reconstruction without rigid joint immobilization

Akinori Kaneguchi et al.

Summary: An animal model of ACLR-induced arthrofibrosis without immobilization was successfully developed in rats, demonstrating a significant increase in joint contracture and fibrosis-related gene expression in the ACLR group compared to the ACLT group. This model is ideal for studying the mechanisms and effectiveness of therapeutic strategies for arthrofibrosis following ACLR.

CONNECTIVE TISSUE RESEARCH (2021)

Article Pharmacology & Pharmacy

Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension

Yifang Li et al.

Summary: Combining BM-MSCs and serelaxin provided broader renoprotection than either therapy alone or perindopril, suggesting a potential novel treatment for hypertensive CKD.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Multifunctional intracellular matrix metalloproteinases: implications in disease

Wesam Bassiouni et al.

Summary: Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that were initially discovered as proteases targeting extracellular proteins. However, recent research has revealed their crucial intracellular roles in various pathological conditions, including cardiovascular renal disorders, inflammation, and malignancy. In addition to MMP-2, at least eleven other MMPs have been identified to function intracellularly, highlighting the importance of understanding their roles in cellular processes and potential as therapeutic targets.

FEBS JOURNAL (2021)

Review Medicine, General & Internal

Dupuytren's Disease-Etiology and Treatment

Mike Ruettermann et al.

Summary: The global prevalence of Dupuytren's disease (DD) is 8%, with genetic factors being the main cause. Limited fasciectomy is the most common treatment, but recurrences can occur in 12-73% of patients within 5 years. Other treatments include percutaneous needle fasciotomy and radiotherapy.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2021)

Article Orthopedics

Pathological changes of frozen shoulder in rat model and the therapeutic effect of PPAR-γ agonist

Jinfu Chen et al.

Summary: The study investigated the effect of TGF-beta on frozen shoulder in rat models and explored the therapeutic effect of PPAR-gamma agonist. Results showed PPAR-gamma agonists may be a promising target for frozen shoulder treatment, reducing inflammation and abnormal cell proliferation.

JOURNAL OF ORTHOPAEDIC RESEARCH (2021)

Article Nanoscience & Nanotechnology

Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis

Mengying Hu et al.

Summary: The study reveals the key role of hepatic macrophages in mediating relaxation-induced alleviation of liver fibrosis. By developing lipid nanoparticles that target activated hepatic stellate cells and encapsulate relaxin gene and miR-30a-5p mimic, a synergistic antifibrosis effect is achieved in mouse liver fibrosis models. This approach demonstrates a proof-of-concept for devising antifibrotic strategies through the complementary application of nanotechnology and basic science.

NATURE NANOTECHNOLOGY (2021)

Article Rheumatology

Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma

Rebecca L. Ross et al.

Summary: Human pDC play a significant role in inflammation and immune-driven skin fibrosis, which can be effectively blocked by BDCA2-targeting, providing direct evidence supporting the development of attenuation of pDC function as a therapeutic application for SSc.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Biochemistry & Molecular Biology

PP2Acα promotes macrophage accumulation and activation to exacerbate tubular cell death and kidney fibrosis through activating Rap1 and TNFα production

Yan Liang et al.

Summary: The study found that PP2Ac alpha promotes macrophage accumulation and activation, accelerating kidney fibrosis. Deleting PP2Ac alpha can reduce kidney fibrosis and related damage. In vitro experiments also showed that PP2Ac alpha deficiency decreases cell motility.

CELL DEATH AND DIFFERENTIATION (2021)

Article Biotechnology & Applied Microbiology

Adapting the Scar-in-a-Jar to Skin Fibrosis and Screening Traditional and Contemporary Anti-Fibrotic Therapies

Joao Q. Coentro et al.

Summary: Skin fibrosis is still an unmet clinical need, and the poor predictive capacity of currently available in vitro fibrosis models hinders their clinical translation. This study utilized macromolecular crowding and TGF beta 1 to develop a skin fibrosis in vitro model and screen a range of anti-fibrotic compounds, demonstrating the potential of macromolecular crowding in the development of in vitro pathophysiology models.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)

Article Medicine, Research & Experimental

Tetrandrine inhibits the occurrence and development of frozen shoulder by inhibiting inflammation, angiogenesis, and fibrosis

Huakun Zhao et al.

Summary: The study demonstrated that TET protected the normal reticular structure of the capsule during the freezing period and prevented the development of FS by inhibiting inflammation, angiogenesis, and fibrosis in a rat FS model.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Cell Biology

Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats

Jingjing Tian et al.

Summary: The study found that the SGLT2 inhibitor dapagliflozin (DAPA) protects against diabetic cardiomyopathy (DCM) and myocardial fibrosis by suppressing fibroblast activation and endothelial-to-mesenchymal transition (EndMT) through the AMPK alpha-mediated inhibition of the TGF-beta/Smad signaling pathway.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Multidisciplinary Sciences

Translational targeting of inflammation and fibrosis in frozen shoulder: Molecular dissection of the T cell/IL-17A axis

Moeed Akbar et al.

Summary: Frozen shoulder is a common fibroproliferative disease with unclear pathophysiological mechanisms, but evidence suggests the involvement of dysregulated immunobiology. IL-17A plays a key role in inflammation and tissue remodeling in frozen shoulder, with potential as a therapeutic target for future management.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Localized chondro-ossification underlies joint dysfunction and motor deficits in the Fkbp10 mouse model of osteogenesis imperfecta

Joohyun Lim et al.

Summary: This study reveals that defects in Fkbp10 in tendons and ligaments can cause joint dysfunction in osteogenesis imperfecta, involving ectopic chondrogenesis and dysregulated Hedgehog signaling.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Editorial Material Medicine, General & Internal

Dupuytren's disease

Marta Karbowiak et al.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Hospitality, Leisure, Sport & Tourism

Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2/3 in rats following myocardial infarction

Yue Xi et al.

Summary: The study found that dynamic resistance exercise can stimulate skeletal muscle to produce FSTL1 protein, promoting myocardial angiogenesis, inhibiting pathological remodeling, and protecting cardiac function. Exogenous FSTL1 can promote endothelial cell proliferation and regulate angiogenesis through the DIP2A-Smad2/3 signaling pathway.

JOURNAL OF SPORT AND HEALTH SCIENCE (2021)

Article Orthopedics

Pathogenesis and Development of Patellar Tendon Fibrosis in a Rabbit Overuse Model

Haitao Liu et al.

AMERICAN JOURNAL OF SPORTS MEDICINE (2020)

Review Rheumatology

Scleroderma mimics - Clinical features and management

Catherine H. Orteu et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2020)

Review Multidisciplinary Sciences

Fibrosis: from mechanisms to medicines

Neil C. Henderson et al.

NATURE (2020)

Article Medicine, Research & Experimental

Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1

Tim Wilhelmi et al.

THERANOSTICS (2020)

Review Ophthalmology

Fibrocytes, Wound Healing, and Corneal Fibrosis

Rodrigo Carlos de Oliveira et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)

Article Gastroenterology & Hepatology

MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappa B-TNF alpha pathway

Tianpeng Zhang et al.

JOURNAL OF HEPATOLOGY (2019)

Article Urology & Nephrology

KLF4 in Macrophages Attenuates TNFα-Mediated Kidney Injury and Fibrosis

Yi Wen et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Multidisciplinary Sciences

Fibroblast activation and inflammation in frozen shoulder

Moeed Akbar et al.

PLOS ONE (2019)

Article Multidisciplinary Sciences

Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis

William A. Blessing et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Chemistry, Medicinal

Effects of losartan and atorvastatin on the development of early posttraumatic joint stiffness in a rat model

Andreas Baranowski et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Urology & Nephrology

AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis

Bryna S. M. Chow et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Cell Biology

Understanding relaxin signalling at the cellular level

Adam L. Valkovic et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)

Article Medicine, General & Internal

Effect of Relaxin Expression from an Alginate Gel-Encapsulated Adenovirus on Scar Remodeling in a Pig Model

In Sik Yun et al.

YONSEI MEDICAL JOURNAL (2019)

Review Cell & Tissue Engineering

Pathological mechanisms and therapeutic outlooks for arthrofibrosis

Kayley M. Usher et al.

BONE RESEARCH (2019)

Article Biochemistry & Molecular Biology

Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis

Reyhaneh Rabieian et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Article Cell Biology

TGF-β1 Signaling and Tissue Fibrosis

Kevin K. Kim et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Review Medicine, Research & Experimental

Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment

Lin Chen et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Gastroenterology & Hepatology

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

Chen Qu et al.

HEPATOLOGY (2018)

Review Biochemistry & Molecular Biology

Inflammation and fibrosis

Matthias Mack

MATRIX BIOLOGY (2018)

Article Cell Biology

Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling

Giulia Boccalini et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)

Review Pharmacology & Pharmacy

TGF beta pathway inhibition in the treatment of non-small cell lung cancer

Pinar O. Eser et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Review Pharmacology & Pharmacy

Anti-fibrotic actions of relaxin

C. S. Samuel et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Review Orthopedics

Arthrofibrosis Associated With Total Knee Arthroplasty

Victor A. Cheuy et al.

JOURNAL OF ARTHROPLASTY (2017)

Review Medicine, General & Internal

Systemic sclerosis

Christopher P. Denton et al.

LANCET (2017)

Review Multidisciplinary Sciences

Inflammation and metabolism in tissue repair and regeneration

Sabine A. Eming et al.

SCIENCE (2017)

Review Cell Biology

Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone

Shinya Ito et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)

Article Gastroenterology & Hepatology

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis

Robert G. Bennett et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2017)

Article Medicine, General & Internal

Relaxin Modulates the Expression of MMPs and TIMPs in Fibroblasts of Patients with Carpal Tunnel Syndrome

Young-Mi Kang et al.

YONSEI MEDICAL JOURNAL (2017)

Article Biochemistry & Molecular Biology

Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties

Thomas Beiert et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Critical Care Medicine

Differential Expression of VEGF-Axxx Isoforms Is Critical for Development of Pulmonary Fibrosis

Shaney L. Barratt et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Review Cell & Tissue Engineering

Mesenchymal Stem Cells in Fibrotic Disease

Elie El Agha et al.

CELL STEM CELL (2017)

Review Clinical Neurology

Carpal tunnel syndrome: clinical features, diagnosis, and management

Luca Padua et al.

LANCET NEUROLOGY (2016)

Review Urology & Nephrology

TGF-β: the master regulator of fibrosis

Xiao-ming Meng et al.

NATURE REVIEWS NEPHROLOGY (2016)

Article Pharmacology & Pharmacy

Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin)

Alessandro Pini et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)

Article Physiology

Modulation of pulmonary fibrosis by IL-13Rα2

Robert V. Lumsden et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)

Article Critical Care Medicine

FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis

Claudia A. Staab-Weijnitz et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Orthopedics

Generation and characterization of a novel shoulder contracture mouse model

Satoshi Oki et al.

JOURNAL OF ORTHOPAEDIC RESEARCH (2015)

Article Endocrinology & Metabolism

Role of Sphingosine Kinase/S1P Axis in ECM Remodeling of Cardiac Cells Elicited by Relaxin

Alessia Frati et al.

MOLECULAR ENDOCRINOLOGY (2015)

Article Biotechnology & Applied Microbiology

Novel Model of Pulmonary Artery Banding Leading to Right Heart Failure in Rats

Masataka Hirata et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Medicine, General & Internal

The elusive Antifibrotic Macrophage

Adhyatmika Adhyatmika et al.

FRONTIERS IN MEDICINE (2015)

Article Biochemistry & Molecular Biology

MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis

Sudipta Das et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)

Review Cardiac & Cardiovascular Systems

Crosstalk between fibroblasts and inflammatory cells

Sophie Van Linthout et al.

CARDIOVASCULAR RESEARCH (2014)

Review Cell Biology

Diverse functions of matrix metalloproteinases during fibrosis

Matthew Giannandrea et al.

DISEASE MODELS & MECHANISMS (2014)

Article Gastroenterology & Hepatology

Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice

Liu Yang et al.

GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Relaxin Modulates Human and Rat Hepatic Myofibroblast Function and Ameliorates Portal Hypertension In Vivo

Jonathan A. Fallowfield et al.

HEPATOLOGY (2014)

Article Peripheral Vascular Disease

Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease

Chrishan S. Samuel et al.

HYPERTENSION (2014)

Article Urology & Nephrology

Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis

Bryna S. Man Chow et al.

KIDNEY INTERNATIONAL (2014)

Article Gastroenterology & Hepatology

Relaxin decreases the severity of established hepatic fibrosis in mice

Robert G. Bennett et al.

LIVER INTERNATIONAL (2014)

Review Pharmacology & Pharmacy

Heat shock proteins in fibrosis and wound healing: Good or evil?

Pierre-Simon Bellaye et al.

PHARMACOLOGY & THERAPEUTICS (2014)

Article Immunology

Relaxin attenuates silica-induced pulmonary fibrosis by regulating collagen type I and MMP-2

Xiao-Feng Li et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2013)

Article Medicine, Research & Experimental

VEGF suppresses epithelial-mesenchymal transition by inhibiting the expression of Smad3 and miR-192, a Smad3-dependent microRNA

Jun-Ping Hong et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

MiR-29 mediates TGF1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts

Tao Yang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2013)

Review Physiology

RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS

R. A. D. Bathgate et al.

PHYSIOLOGICAL REVIEWS (2013)

Article Rheumatology

Animal Models of Scleroderma: Current State and Recent Development

Yoshihide Asano et al.

CURRENT RHEUMATOLOGY REPORTS (2013)

Article Physiology

Relaxin protects against renal ischemia-reperfusion injury

Takuya Yoshida et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)

Article Urology & Nephrology

Neutralization of Tumor Necrosis Factor-Alpha Reduces Renal Fibrosis and Hypertension in Rats with Renal Failure

Frederick J. Therrien et al.

AMERICAN JOURNAL OF NEPHROLOGY (2012)

Article Peripheral Vascular Disease

Interleukin 6 Underlies Angiotensin II-Induced Hypertension and Chronic Renal Damage

Weiru Zhang et al.

HYPERTENSION (2012)

Article Rheumatology

Expression of RXFP1 in skin of scleroderma patients and control subjects

N. Giordano et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)

Article Pathology

Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis

Xiangwei Huang et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Article Biochemistry & Molecular Biology

Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice

Izumi Onozuka et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Reproductive Biology

Relaxin Modulates Proinflammatory Cytokine Secretion from Human Decidual Macrophages

J. S. Horton et al.

BIOLOGY OF REPRODUCTION (2011)

Article Orthopedics

Frozen shoulder: a consensus definition

Joseph D. Zuckerman et al.

JOURNAL OF SHOULDER AND ELBOW SURGERY (2011)

Review Orthopedics

Dupuytren Disease: An Evolving Understanding of an Age-old Disease

Eric M. Black et al.

JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2011)

Article Endocrinology & Metabolism

Relaxin inhibits early steps in vascular inflammation

Anna Brecht et al.

REGULATORY PEPTIDES (2011)

Review Orthopedics

Adhesive Capsulitis A Review of Current Treatment

Andrew S. Neviaser et al.

AMERICAN JOURNAL OF SPORTS MEDICINE (2010)

Article Pharmacology & Pharmacy

Prevention of Bleomycin-Induced Pulmonary Fibrosis by a Novel Antifibrotic Peptide with Relaxin-Like Activity

Alessandro Pini et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

Review Rheumatology

Scientific understanding and clinical management of Dupuytren disease

Barbara Shih et al.

NATURE REVIEWS RHEUMATOLOGY (2010)

Review Allergy

Recent Advances in the Treatment of Systemic Sclerosis

Vasiliki Kalliopi K. Bournia et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2009)

Article Biochemistry & Molecular Biology

Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

Ishanee Mookerjee et al.

FASEB JOURNAL (2009)

Article Orthopedics

Arthrogryposis: A Review and Update

Michael Bamshad et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)

Article Urology & Nephrology

Loss of TIMP3 Enhances Interstitial Nephritis and Fibrosis

Zamaneh Kassiri et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Review Urology & Nephrology

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy

Robert L. Chevalier et al.

KIDNEY INTERNATIONAL (2009)

Review Medicine, Research & Experimental

Mechanisms of fibrogenesis

Tatiana Kisseleva et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2008)

Review Immunology

Th17 cytokines and their emerging roles in inflammation and autoimmunity

Lynette A. Fouser et al.

IMMUNOLOGICAL REVIEWS (2008)

Article Cell Biology

Fibroblast migration is mediated by CD44-dependent TGFβ activation

Pinak S. Acharya et al.

JOURNAL OF CELL SCIENCE (2008)

Review Oncology

Cellular and molecular mechanisms of fibrosis

T. A. Wynn

JOURNAL OF PATHOLOGY (2008)

Article Medicine, General & Internal

Expression of Transforming Growth Factor-beta 1 and Connective Tissue Growth Factor in the Capsule in a Rat Immobilized Knee Model

Yoshihiro Hagiwara et al.

UPSALA JOURNAL OF MEDICAL SCIENCES (2008)

Article Cell Biology

Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling

Lucia Formigli et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)

Article Biochemistry & Molecular Biology

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Elisabeth M. Zeisberg et al.

NATURE MEDICINE (2007)

Article Biotechnology & Applied Microbiology

Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats

Ying-Bin Hu et al.

JOURNAL OF GENE MEDICINE (2007)

Review Cell Biology

Matrix metalloproteinases and the regulation of tissue remodelling

Andrea Page-McCaw et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)

Review Pharmacology & Pharmacy

Relaxin - a pleiotropic hormone and its emerging role for experimental and clinical therapeutics

Thomas Dschietzig et al.

PHARMACOLOGY & THERAPEUTICS (2006)

Article Biochemistry & Molecular Biology

IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis

S Fichtner-Feigl et al.

NATURE MEDICINE (2006)

Review Critical Care Medicine

Complications after tibia plateau fracture surgery

Panayiotis J. Papagelopoulos et al.

INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2006)

Article Respiratory System

The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis

V Barbarin et al.

RESPIRATORY RESEARCH (2005)

Article Dermatology

The relaxin gene knockout mouse: A model of progressive scleroderma

CS Samuel et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)

Review Cell Biology

Procollagen trafficking, processing and fibrillogenesis

EG Canty et al.

JOURNAL OF CELL SCIENCE (2005)

Article Orthopedics

Perfomance of a high-repetition, high-force task induces carpal tunnel syndrome in rats

BD Clark et al.

JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY (2004)

Article Gastroenterology & Hepatology

Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis

F Siller-López et al.

GASTROENTEROLOGY (2004)

Article Transplantation

Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro

R Masterson et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)

Review Physiology

Emerging role of relaxin in renal and cardiovascular function

KP Conrad et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)

Article Orthopedics

A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome

AM Ettema et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)

Review Pharmacology & Pharmacy

Collagens -: structure, function, and biosynthesis

K Gelse et al.

ADVANCED DRUG DELIVERY REVIEWS (2003)

Article Immunology

Dual roles of IL-4 in lung injury and fibrosis

F Huaux et al.

JOURNAL OF IMMUNOLOGY (2003)

Article Gastroenterology & Hepatology

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat

Y Iimuro et al.

GASTROENTEROLOGY (2003)

Review Rheumatology

Cytokine directed therapy in scleroderma: rationale, current status, and the future

RW Simms et al.

CURRENT OPINION IN RHEUMATOLOGY (2002)

Article Physiology

Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout mice

G Izbicki et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)

Article Biochemistry & Molecular Biology

Relaxin activates the MAP kinase pathway in human endometrial stromal cells

Q Zhang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2002)

Article Physiology

IL-12 attenuates bleomycin-induced pulmonary fibrosis

MP Keane et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2001)

Article Medicine, General & Internal

Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial

JR Seibold et al.

ANNALS OF INTERNAL MEDICINE (2000)

Article Rheumatology

Scleroderma and related disorders: therapeutic aspects

CP Denton et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2000)